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Abstract  1 
Background: It is important to share information about other countries’ pharmacists in 2 
order to medically cooperate with other countries effectively. However, there has not 3 
been much harmonization in relation to the medical practices of various countries. 4 
Objectives: This study investigates the dispensing systems and the work done by 5 
pharmacists in the United Kingdom, Germany, France, Thailand, and Malaysia. We 6 
aimed to compare these countries’ medical practices in order to develop a cohesive 7 
vision for the future of Japanese pharmacists.  8 
Methods: An academic study was conducted using the relevant literature in the field. 9 
Hospitals and pharmacies in Thailand and Malaysia were also visited and interviews 10 
were conducted therein.  11 
Results: All five of the countries studied had dispensing assistants. Pharmacists in Japan 12 
have duties of inventory control, drug dispensing, and providing medication advice. In 13 
contrast, these assistants working in other countries are responsible for some aspects of 14 
dispensing and inventory control, allowing the pharmacists to spend their time and 15 
competency in instructing patients on how to take their medication. Because of this, 16 
pharmacists were actively involved with health promotion intervention in the United 17 
Kingdom, Germany, and France.  18 
Conclusions: We wish that the work done by Japanese pharmacists would transition 19 
from primarily dispensing drugs to patient care, advice, and counseling in order to 20 
enrich overall health promotion and health/nutrition counseling. 21 
 22 
Keywords Role of the pharmacist, Dispensing system, Pharmacy assistant, Team 23 
medical care, Health promotion, 24 
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1. Introduction 1 
Pharmacists are experts in dispensing medicine and providing relevant medical advice. 2 
Recently, the pharmaceutical field has transformed itself from a product- and 3 
task-oriented (dispensing) profession to a patient-oriented profession (provision of care, 4 
advice, and counseling).1 In Japan, hospital pharmacists presently participate in 5 
team-based healthcare services by providing pharmaceutical services in wards and at 6 
patients’ bedsides in an attempt to better understand patients’ disease states and 7 
appropriate medical treatment.  8 
On the other hand, community pharmacists dispense prescriptions for outpatients, 9 
recommend non-prescription drugs, and perform various other related activities. As a 10 
result, community pharmacists must perform medication history management and check 11 
for drug interactions to ensure the proper use of medicine and safety.2 In addition, in 12 
response to the increasingly aging society, the Long-Term Care Insurance Act was 13 
enacted in 2000, giving pharmacists the ability to join as medical staff members. 14 
Recently, several developed countries have reported similar new roles for community 15 
pharmacists in the multidisciplinary provision of health promotion.  16 
For example, in the United States, Collaborative Drug Therapy Management (CDTM)3 17 
is popular for anticoagulation therapy, diabetes, and hyperlipidemia. Pharmacists 18 
monitor diseases, change prescriptions, and deliver drugs in pharmacies according to 19 
their contracts with doctors. Furthermore, community pharmacies have the advantage of 20 
extended business hours and convenient locations. Therefore, community pharmacists 21 
routinely provide immunizations in order to improve influenza coverage.4 In the United 22 
Kingdom (UK), the Patient Group Direction (PGD).5 is changing the way pharmacists 23 
sort and deliver specific prescriptions, to better regionalize patient care. This change, in 24 
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particular, affects emergency contraception, tobacco cessation programs, etc. 1 
Additionally, pharmacists can get qualified as Independent Prescribers (IPs).6 to perform 2 
diagnoses and prescribe medications for chronic diseases through specialized training. 3 
Furthermore, the UK government is currently supporting the transferal of the 4 
management of minor ailments from general practitioners (GPs) to pharmacies, termed 5 
community pharmacy minor ailments schemes7-9; this has recently been introduced in 6 
Nottingham City10). In Germany, 24-hour prescription provision is possible, and 7 
pharmacists work on rotating schedules in each district. Pharmacists are active in many 8 
different prevention programs, and there is great interest in pharmacy-based preventive 9 
care counseling.11 These types of programs include blood pressure measurement, blood 10 
glucose measurement, cholesterol measurement, prevention of vein thrombosis, 11 
osteoporosis prevention, general nutrition counseling, and vaccination counseling.  12 
Medical care and the role of the pharmacist are expected to change more rapidly in the 13 
coming years. It is important to share information about pharmacist tasks in other 14 
countries to foster a stronger sense of medical cooperation. However, to date, there has 15 
not been much harmonization in pharmacists’ practices across various countries. This 16 
study investigates the dispensing systems and the work done by pharmacists in the UK, 17 
Germany, France, Thailand, and Malaysia. Furthermore, this review will compare the 18 
pharmaceutical occupation in Japan with that of these five countries.  19 
The historical background section summarizes population distribution, causes of death, 20 
total pharmacist/pharmacy/pharmacy assistant numbers, pharmacy education, and 21 
medical insurance. The dispensing system section summarizes the medicine supply; the 22 
presence or absence of refills, repeat prescriptions, and dispensing doctors; and the 23 
regulatory classification of the medicine. This review clarifies the differences in the 24 
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dispensing systems and the work done by pharmacists between Japan and five other 1 
countries. Moreover, the present review suggests several future directions for 2 
pharmacists in Japan. 3 
 4 
2. Methods 5 
We targeted the three developed countries—UK, Germany, and France—and two 6 
developing countries—Thailand and Malaysia. Our academic study was conducted 7 
using the relevant literature. Hospitals and pharmacies in Thailand and Malaysia were 8 
also visited, and interviews were conducted to gather information on the medical 9 
insurance systems, pharmacists’ preferred dispensing systems, and the duties of the 10 
pharmacists and pharmacy assistants.  11 
Information concerning the trends in the scope of the pharmacy business was exchanged 12 
with local pharmacists in the UK and Germany via e-mail. Statistical data originated 13 
from the UN’s World Population Prospects: The 2010 Revision; World Health Statistics 14 
2013; World Health Organization 2013; 2012 FIP Global Pharmacy Workforce Report; 15 
and the 2013 FIP Ed Global Education Report. A chart comparing Japan with the 16 
previously mentioned countries was created based on the contents of this investigation. 17 
 18 
3. Results 19 
3-1 Historical background 20 
Figure 1 shows the demographic composition of each country (UN, World Population 21 
Prospects: The 2010 Revision). Demographic changes were represented by a pot-shaped 22 
curve (in Japan, UK, and Germany), a bell-shaped curve (in France), and a 23 
pyramid-shaped curve (in Malaysia and Thailand; Fig.1). As for the age distribution of 24 
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the population, Japan had 31% over 60 and 13% under 15 years old; the UK had 23% 1 
over 60 and 17% under 15; Germany had 26% over 60 and 13% under 15; France had 2 
23% over 60 and 18% under 15; Thailand had 13% over 60 and 20% under 15; and 3 
Malaysia had 8% over 60 and 30% under 15 (World Health Statistics 2013).  4 
The top 10 disease-related causes of death in the different countries are shown in Table 5 
1 below (World Health Organization 2013). In Japan, UK, Germany, and France, the top 6 
3 disease-related causes of death were cardiovascular disease, cancer, and 7 
cerebrovascular disease, whereas in Malaysia and Thailand, infection and neonatal 8 
diseases were among the highest.  9 
The pharmaceutical situations of each country are shown in Table 2 (2013 FIP Ed 10 
Global Education Report and the 2012 FIP Global Pharmacy Workforce Report). There 11 
were 276,517 pharmacists in Japan, 50,664 in the UK, 78,322 in Germany, 73,259 in 12 
France, 28,272 in Thailand, and 8,993 in Malaysia. The five countries excepting Japan 13 
had dispensing assistants. The pharmacy technician provides essential support to the 14 
pharmacist in areas including prescription entry, third-party insurance management, 15 
staff/patient scheduling, dispensing, and inventory control.12 16 
There were 71,970 total pharmacies in Japan, 13,264 in the UK, 21,860 in Germany, 17 
25,426 in France, 11,592 in Thailand, and 2,330 in Malaysia. The number of certified 18 
pharmacy graduates per year was 9,912 in Japan, 2,800 in the UK, 1,868 in Germany, 19 
3,000 in France, 1,680 in Thailand, and 1,208 in Malaysia. 20 
 21 
3-2 Medical insurance system  22 
A description of the health care systems for each country is shown in Table 3.  23 
(1) Japan 24 
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Japan’s universal health insurance system was established in 1961. Under this system, 1 
all citizens are required to join the public health insurance system according to their 2 
occupation. There are several types of health insurance, such as that for office workers 3 
and government employers, the National Health Insurance system (serving 4 
self-employed and farmers), and a medical insurance system specifically for the elderly 5 
aged 75 and over. This last system was intended for people who are 75 years old or over 6 
or who are between 65 and 75 and are bedridden.  7 
In 1974, the separation of dispensing and prescribing medications started in the wake of 8 
increased prescription charges (reaching 500 yen). However, in 2012, the national 9 
average extramural dispensing percentage remained at 66.1% (Fig.2). Highest 10 
percentages by prefecture were Akita (82.7%), Kanagawa (78.8%), and Niigata (76.7%). 11 
The lowest percentages by prefecture were Fukui (37.8%), Wakayama (42.4%), and 12 
Kyoto (46.7%). 13 
(2) United Kingdom 14 
In the UK, under the government-managed National Health Service (NHS), which is 15 
financed by taxes, all citizens can receive medical services free of charge.13 The content, 16 
budgeting, and guidelines for medical services are set and operated by each Primary 17 
Care Trust (PCT, or local insurance trade association), of which there are about 150 in 18 
total. After all citizens select a GP, they are entered into the system to receive medical 19 
services. Pharmacy services are broken down into three classifications: (a) Essential 20 
Services, (b) Advanced Services, and (c) Enhanced Services. Essential Services are 21 
provided by all community pharmacies contracted by the NHS. These services include 22 
prescription dispensing, repeat dispensing, disposal of unwanted medicine, promotion 23 
of healthy lifestyles, and supply of appliances. Advanced Services require pharmacists 24 
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to take certifications through lifelong learning courses and university courses. These 1 
services include medicines use review (MUR), appliance use review, stoma appliance 2 
customization, and New Medicine Service. An MUR is a consulting service that allows 3 
patients who have problems with their medications to request prescription changes from 4 
the prescribing doctor after consulting with a pharmacist, who confirms the patient’s 5 
medication status and side effects. Enhanced Services are services granted to each 6 
district by the PCT, such as outside hours, health checks, protective vaccinations 7 
(influenza vaccines and cervical cancer prevention), smoking cessation programs, and 8 
hormonal contraception.14 (Table 4).  9 
(3) Germany 10 
The foundation of Germany’s public health insurance system was the law enacted by 11 
Otto von Bismarck in 1883. Following this, the Empire Insurance Ordinance was 12 
enacted in 1911 in an attempt to protect the population from diseases, and this forms the 13 
root of the compulsory insurance system (district disease safe: AOK; companies disease 14 
safe: BKK; brethren disease safe: IKK; and staff alternative disease safe: AKE). The 15 
universal health insurance system was established in 2009, after which roughly 90% of 16 
the population has taken out public health insurance, and 10% has taken out private 17 
health insurance. Outpatient care is conducted by an insurance doctor who has a 18 
contract with the disease safe programs. First, patients must see a family doctor, after 19 
which they are evaluated by a specialist, as necessary. 20 
(4) France 21 
Under the universal health insurance system, medical insurance is classified according 22 
to occupation: the general system (regimes general), self-employed insurance system 23 
(regimes non salaries), special system (regimes speciaux), and agricultural society 24 
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mutual aid system (regimes agricoles). In order to receive insurance benefits, patients 1 
must register to see a "family doctor." If necessary, they visit a specialist called a 2 
cooperation physician. In the case of outpatient medical care, the insured person pays 3 
for the full amount of medical fees, in principle. After that, they send the doctor’s 4 
receipt (including the pharmacy cost, if there is a prescription drug) to the sick fund, and 5 
are reimbursed. On the other hand, in the case of inpatient care, the patient’s payment to 6 
the facility is only fee they must pay; the rest are in-kind benefits. 7 
(5) Thailand  8 
The health care system in Thailand has three parts: (d) government employment, (e) 9 
social insurance, and (f) universal coverage. Government employees can receive 10 
medical services free of charge, without the burden of insurance premiums. However, in 11 
cases where patients demand to be seen by a doctor in a private hospital or to use 12 
original drugs, medical costs are paid out of pocket. Office workers prepay insurance 13 
costs to NHSO in order to receive medical services free of charge when they visit the 14 
hospital. As for the general public, visits are first made to a clinic. After that, they visit 15 
the hospital, if necessary. In addition, Thailand has a Medicine List, which offers 16 
different benefits in terms of the ranges of drugs that can be used, depending on the type 17 
of insurance coverage. 18 
(6) Malaysia 19 
There is no public health insurance in Malaysia. Malaysians can visit the government 20 
hospitals and clinics at a price of about 0.25 euros (about 1 Ringgit: Malaysia monetary 21 
unit), which is paid by the government. However, public officials and those with low 22 
incomes can receive medical services free of charge. Private hospitals are developing 23 
business projects that target high-income and high-net-worth foreigners. 24 
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 1 
3-3 Pharmacists’ dispensing systems  2 
The dispensing system of the pharmacists in each country is shown in Table 5. The 3 
supply of pharmaceutical products and the dispensing process in Japan differ from the 4 
adopted packaging unit (i.e., “box out”) system used in the UK, Germany, France, 5 
Thailand, and Malaysia. The counting dispensing system refers to a system wherein 6 
medicine is counted out for each individual patient. The box out system refers to 7 
delivering already-packaged medicine to the patient. Packaging units are set in 8 
accordance with the adaptation. For example, most medicines are packaged in units of 9 
28 tablets, or 30 tablets for chronic disease, because it is standard to administer 10 
medication for one month. Most antibiotics, on the other hand, have units of 5 or 7 11 
tablets per box. Then, the dispensing assistant attaches a label printed to the medication, 12 
including the patient’s name and instructions for taking the medication.  13 
In the UK, dispensing of medicine in the form of powders, liquids, and ointments has 14 
been banned (the mixture dispensing business is not been performed, save for in 15 
educational hospitals). Children and patients with dysphagia are supported by 16 
ready-made foaming agents or chewable tablets. Refill or repeat prescription has been 17 
adopted in four of the countries, excluding Japan and Germany. Prescription refills refer 18 
to whether a pharmacist can dispense a given medicine repeatedly within the valid refill 19 
prescription period. Repeat prescriptions refer to the ability to dispense a given 20 
medicine for patients with chronic illnesses in combination with the "parent 21 
prescription" and "child prescription."  22 
The UK and France have legally permitted prescription rights for pharmacists; however, 23 
Japan, Germany, Thailand, and Malaysia have not permitted such rights. In recent years, 24 
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there has been a movement toward pharmacists being actively engaged in: (1) making 1 
prescription suggestions for avoiding side effects and ensuring the efficacy of the 2 
medicine, and (2) formulating hospital protocol for proper use of time in consultations 3 
with the doctor. The division of prescriptions in the UK is shown in Table 6. 4 
Prescriptions are classified into one of four types: Green (prescribed by GPs), Blue 5 
(prescription of controlled drugs such as methadone), Yellow (prescribed by dentists), 6 
and Lilac (prescriptions by pharmacists and nurses recognized as “auxiliary 7 
prescriptions” and “independent prescriptions”). Pharmacists in the UK have been 8 
recognized as being responsible for “auxiliary prescriptions”—that is, changing the 9 
amount of drug supplementation based on the prescription and doctor’s diagnosis—and 10 
“independent prescriptions”—that is, carrying out prescriptions and diagnosis in a 11 
specialized field. This pharmacist responsibility is explicitly stated in Vacherot Low’s 12 
(HPST low) Article 36 in France. For dispensing doctors in Japan, "dispensing is a 13 
monopoly business of the pharmacist." However, it is a recognized fact that dispensing 14 
doctors are bound by law—specifically, Article 22 of the Medical Practitioners Law, 15 
Article 19 of the Pharmacists Act, and Article 21 of the Dental Practitioners Law. The 16 
UK, Germany, and France do not have basic dispensing doctors, save for special cases 17 
limited to the patients living in such rural and remote areas. This been observed in 18 
private clinics and hospitals in Malaysia and Thailand as well. 19 
 20 
3-4 Regulatory classification of medicine 21 
The classification of medicine in each country is shown in Table 7. In Japan, it is 22 
classified into two types: (A) prescription drugs and (B) over-the-counter drugs. 23 
Depending on the risk degree of the side effects, pharmaceuticals are classified 24 
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according to different schedules: ScheduleⅠ(pharmaceutical products with especially 1 
high risk: sale possible only by pharmacists); Schedule Ⅱ (pharmaceutical products 2 
with relatively high risk); and Schedule Ⅲ (pharmaceutical products with relatively 3 
low risk). In the UK, the drugs are classified into three types: (C) Prescription-Only 4 
Medicine (POM); (D) Pharmacy Medicine (P); and (E) General Sales List Medicine 5 
(GSL). POM is dispensed according to a doctor's prescription. P is sold under the 6 
supervision of a pharmacist, and is also known as "behind-the-counter" drugs. It is 7 
possible to sell GSL in supermarkets, convenience stores, and gas stations that do not 8 
have pharmacists. These are also termed “over-the-counter” drugs.  9 
However, in the absence of a supervising pharmacist who is able to sell POM, P and 10 
GSL can be sold in pharmacies because sales methods are defined such that the 11 
medicine handled in the pharmacies of health care provider facilities should be sold 12 
with supervising pharmacist guidance and supervision to the patient. In Germany, drugs 13 
are classified into three types: (F) “needed prescription drugs” (Verschreibungspflidhtig), 14 
(G) “pharmacy-indicated drugs” (Apothekenpflichtig), and (H) “free-sale products” 15 
(Freiverkauferlich). Pharmacy-indicated drugs are available without prescriptions, but 16 
they cannot be sold outside pharmacies. Free-sale products are sold in drugstores and 17 
supermarkets, and in many cases are herbal preparations.  18 
In France, drugs are classified into two types: (I) PMO (Presctipyion Medicale 19 
Obligatoire) and (J) PMF (Prescription Medicale Facultative). PMO refers to 20 
prescription drugs, while PMF are available without a prescription (refunds are possible 21 
via health insurance payments if they have been prescribed). In Thailand, drugs are 22 
classified into four types: (K) specially controlled medicines, (L) dangerous medicines, 23 
(M) ready-packed pharmaceuticals, and (N) home remedies. Specially controlled 24 
12 
 
medicines can be sold only with prescriptions by pharmacists. Dangerous medicines can 1 
be sold without prescription, but only by pharmacists. Ready-packed medicines can be 2 
sold without prescriptions. Home remedies are common medicines for minor ailments. 3 
No license is needed to sell them. In Malaysia, drugs are classified into three types: (O) 4 
Group B, (P) Group C, and (Q) Non-Poisonous Drugs. Group B refers to medicine that 5 
pharmacists dispense based on doctor prescriptions. Group C refers to medicine sold 6 
according to the management and guidance of the pharmacist, and does not require a 7 
prescription. It is necessary to fill out the patient's name and address at the time of 8 
purchase. NP refers to over-the-counter drugs. 9 
 10 
3-5 Dispensing system in Thailand  11 
The prescriptions define drug prices and provide a method for reducing medical costs in 12 
government hospitals. Community health care facilities or drugstores provide 13 
out-of-hospital prescriptions. In addition, this system carries out free-of-charge oral 14 
examinations, non-smoking programs, blood pressure measurements, and blood glucose 15 
leadership, and nutritional guidance, all funded by the Community Pharmacy 16 
Association. 17 
 18 
3-6 Dispensing system of Malaysia  19 
The prescriptions are received at a patient’s address and result from a disease diagnosis 20 
occurring in a government hospital. In addition, the patient waiting time is less than 30 21 
minutes. A bell rings if the limit exceeds about 20 minutes. Delivery of pharmaceutical 22 
products is also carried out. 23 
In both Malaysia and Thailand, dispensing assistants performs the actual dispensation, 24 
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such as choosing the medicines and handing them to the patient. On the other hand, 1 
pharmacists ensure patient safety in pharmaceutical administration by looking through 2 
the patient’s medical files at the hospital. However, there is a limit to the pharmaceutical 3 
repertoire of the dispensing assistant. Specifically, to manage safety, pharmacists must 4 
dispense high-risk drugs. In most regions, pharmacists are not residents; however, 5 
pharmacists in the chain pharmacies in urban areas are generally residents, although this 6 
has been affected by the pharmacist shortage.  7 
 8 
4. Discussion 9 
From the results presented in Table 1, it is clear that the health care system differs across 10 
each country. This is partly because the disease structure differs between developing and 11 
developed countries. As the results in Table 2 show, Japan has the highest numbers of 12 
pharmacists, pharmacies, and pharmacist training schools compared to the other 13 
countries. In other countries, there are dispensing assistants and professional schools for 14 
dispensing assistants. Rouse et al. defined a pharmacy technician as “… an individual 15 
working in a pharmacy who, under the supervision of a licensed pharmacist, assists in 16 
pharmacy activities that do not require the professional judgment of a pharmacist.”15  17 
The increasing need for pharmacy technicians is related to the myriad changing 18 
dynamics in the healthcare system over the past decade. A growing demand for 19 
clinically focused pharmaceutical care, greater use of prescription drugs, a renewed 20 
emphasis on medication safety, and the growth of retail pharmacies have made the need 21 
for experienced, trained pharmacy technicians an important component to consider 22 
when attempting to support understaffed pharmacies.16 Whereas pharmacists carry out 23 
the flow of inventory management, dispensing, and medication instruction in Japan, 24 
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with a competent dispensing assistant, pharmacists would be able to spend more time 1 
and focus their abilities on patient care opportunities, as in the other countries studied. 2 
Therefore, hiring more dispensing assistants will increase the efficiency of medical 3 
services and reduce the burden faced by the pharmaceutical business. There is a real 4 
need for developed countries to expand individual consultations by pharmacists by 5 
shifting typical pharmacist duties to the dispensing assistants.  6 
Patients cannot see a doctor in a hospital or a specialist if they are not introduced by 7 
their family doctors in the UK, Germany, or France. Individuals typically have to wait a 8 
few months to receive treatment, with the exception of severe or emergency cases.17 9 
Evidence shows that 40% of GPs’ time is spent dealing with patients who have minor 10 
illnesses and that almost two-thirds of those consultations result in a prescription for 11 
medicine or advice which could have been obtained in a pharmacy.18 The UK 12 
government is currently supporting moves to transfer the management of minor 13 
ailments from GPs to pharmacies, including “community pharmacy minor ailments 14 
schemes.”10 Increasing trust should continue to build said schemes, although there are 15 
some important issues (e.g., the restricted formulary, the lack of privacy in some 16 
pharmacies) that need to be addressed to improve and develop the service further.19 In 17 
Germany, pharmacists reported being active in many different prevention subjects, and 18 
there is a great interest in pharmacy-based preventive care counseling.11  19 
In the survey, many customers showed a great interest in topics that have a high 20 
prevalence or socioeconomic burden, like cardiovascular diseases, immunization status, 21 
or diabetes mellitus. Most pharmacists offer blood pressure measurements as well as 22 
blood glucose and cholesterol level measurements. Community pharmacies may be able 23 
to influence individuals who are not patients via commercial over-the-counter drug 24 
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purchases.20  1 
The pharmacist plays a crucial role in early contact with preventive care. Regarding the 2 
dispensing system, the advantage of the box-out system can be measured in terms of its 3 
good quality control and ease of dispensation (Table 5). This could lead to prevention of 4 
dispensing errors and more efficient overall operations. The advantages of refill or 5 
repeat prescriptions were considered to be not having to send the patient to the hospital 6 
and making it possible for a doctor to spend more of their time examining critically ill 7 
patients. The disadvantage of this prescription system is that there is a possibility that 8 
side effects and discovery of disease change may be delayed with prolonged 9 
prescriptions. Dispensing doctors have often been reported to overprescribe to earn 10 
more profit and for making dispensing errors.21 Therefore, this was considered to be an 11 
important factor in the potential for near-misses in improper medicine use in Japan, 12 
Thailand, and Malaysia. 13 
Because there are no pharmacies or hospitals in rural and remote areas, there is a 14 
reduced medical supply. This causes problems such as a lack of or incorrect medication 15 
lists, expired medications, drug interactions (including those involving over-the-counter 16 
medications), adverse drug events, adherence deficiencies, and potentially inappropriate 17 
medications. Medication adherence was significantly improved by incorporating 18 
pharmacists as members of health care teams in direct patient care.22 Full cooperation in 19 
practitioner–pharmacist interactions is, therefore, necessary.23  20 
There are some medicines that can be purchased from pharmacists without prescriptions 21 
in Thailand and Malaysia (Table 7). This is considered beneficial in terms of patient 22 
convenience, but it may lead to negative health effects. Non-prescribed antibiotics may 23 
be used inappropriately due to a lack of health professional supervision.24 For example, 24 
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in Lao People’s Democratic Republic,25 non-prescribed antibiotics are mostly used for 1 
treating the common cold, a viral condition for which antibiotic treatment is 2 
ineffective.26 As a result, self-medication with antibiotics may be associated with 3 
undesirable effects, such as decreased effectiveness and worsening clinical conditions, 4 
and it is one of the main causes of antimicrobial resistance.27  5 
Pharmacy health promotion services have been widely used in developed countries, thus 6 
broadly increasing the roles of the pharmacy/pharmacist (Table 8). In addition to 7 
monitoring patients with chronic diseases, pharmacies provide preventive care services 8 
and health maintenance. For this reason, it is suggested that the community pharmacy 9 
functions as a consultation service for healthy individuals. Compared to other countries, 10 
Japan’s pharmacies have fewer health promotion services. In recent years, it has become 11 
possible to perform tests of blood glucose levels, HbA1c, and hepatic functions for 12 
preventing lifestyle-related diseases. From the above results, it is clear that the 13 
pharmacist is engaged in dispensing medication instructions and supervisory dispensing 14 
in developed countries (the UK, Germany, and France). In addition, out-of-hospital 15 
prescriptions need to be promoted. A wide range of health promotion activities has been 16 
made possible by government support. There is a great need for pharmacists to increase 17 
their abilities and enhance confidentiality practices, to ensure patient privacy. 18 
Furthermore, they should expand their advertisements of appropriate services and 19 
education about service delivery. On the other hand, the pharmacist ensures patient 20 
safety by performing pharmaceutical administration via accessing patient medical files 21 
in hospitals in developing countries (Thailand and Malaysia). Additionally, in-hospital 22 
prescriptions need to be more widely promoted. There is a chance of failure in 23 
out-of-hospital prescription dispensing because of the current pharmacist shortage, poor 24 
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relationships between pharmacists and physicians, lack of access to patient information, 1 
and a general lack of funds.28 2 
Therefore, pharmacists’ activities should center around hospitals. In addition, 3 
pharmacies do not position their services as frontline primary healthcare providers, 4 
which is considered one of their main flaws. Developing countries such as Thailand and 5 
Malaysia are generally more limited in their traditional roles of drug dispensing and 6 
limited medication advice as compared with developed countries. In the future, it will 7 
be necessary to consider developing more detailed pharmaceutical schemes in Thailand 8 
and Malaysia. 9 
 10 
5. Conclusion 11 
It is hoped that pharmacists would make the transition from dispensing drugs as part of 12 
patient care to offering advice and counseling to patients in order to improve health 13 
promotion and health/nutrition counseling. 14 
 15 
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Fig.1 Population distribution
Source: UN, World Population Prospects: The 2010 Revision (2010 data), world health statistics 2013 (2011 data)
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High-income country Low-and middle-income countries
Japan, United Kingdom, 
Germany, France
South-East Asia Region Western Pacific Region
Rank Thailand Malaysia
1 Cardiovascular diseases Cardiovascular diseases Cardiovascular diseases
2 Cancers Infectious diseases Cancers
3
Neurological and 
sense organ conditions Injuries Respiratory disease
4 Respiratory disease Respiratory disease Injuries
5 Injuries Cancers Infectious diseases
6 Infectious diseases Neonatal conditions
Endocrine, blood, immune 
disorders, diabetes mellitus
7 Digestive diseases Digestive diseases Digestive diseases
8
Endocrine, blood, immune 
disorders, diabetes mellitus
Endocrine, blood, immune disorders, 
diabetes mellitus Neonatal conditions
9 Genitourinary diseases Genitourinary diseases Genitourinary diseases
10
Mental and behavioral 
disorders
Neurological and 
sense organ conditions
Neurological and 
sense organ conditions
Source: World Health Organization 2013 (2011data)
Table1 The top 10 causes of death
Japan
United 
Kingdom
Germany France Thailand Malaysia
Human resources
Pharmacists 276,517 50,664 78,322 73,259 28,272 8,993
Pharmacy technician 0 21,000 52,882 － 5,126 3,409
Establishments
Total pharmacies 71,970 13,264 21,860 25,426 11,592 2,330
Education
Pharmacies graduates/year 9,912 2,800 1,868 3,000 1,680 1,208
Schools
Pharmacy 74 26 22 24 19 17
Pharmacy technicians 0 － 93 70 17 33
Academic programme
Degree Type B M B D, P B, P D, B
Length (years) 6 4 5 4, 5 5, 6 3,4
Practical training
Practice C,H C,H,I C,H,I C,H,O C,H,I,O C,H,I,O
Total length (months) 5 12 12 8 6 12
D: Diploma, B: Bachelor, M: Master, P: Vocational Doctorate (Pharm.D)
C: Community Pharmacy, H: Hospital Pharmacy, I: Industry, O: Other
Source: 2012 FIP Global Pharmacy Workforce Report, 2013 FIP Ed Global Education Report
Table2 Comparison of pharmacy 
Fig.2 Extramural dispensing percentage in Japan
Source: Japan Pharmaceutical Association 2013
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Table3  Medical insurance classification
Country Type
Japan Bismarck* Social insurance, National health insurance, 
Medical insurance system for the elderly aged 75 or over: Universal health insurance
United
Kingdom
Beverage# NHS (National Health Service Act of 1946)
Essential Service, Advanced Service, Enhanced Service
Germany Bismarck* Public medical insurance, Private medical insurance： Universal health insurance
France Bismarck* Regimes general, Regimes non salaries, Regimes speciaux, Regimes agricoles
Thailand - Government employ, Social insurance, Universal coverage
Malaysia -
By government spending budget, people can be guaranteed inexpensive medical care 
in government hospital.
* Bismarck: Social security system (Depending on income, people pay.)
# Beverage: Operated by tax (In principle, people pay a certain fee.)
Service 
Component
Service level with English NHS pharmacy contract
Essential Advanced Enhanced
Funding National National Local
Regulation
Compulsory registration
with GPhC*
Accreditation of premises
and pharmacist
Varied, determined 
locally
Examples Prescription dispensing Medicines use review Outside hours
Repeat dispensing Appliance use review Health check
Disposal of unwanted 
medicine
Promotion of healthy 
lifestyles
Supply of appliances
Stoma appliance customization
New Medicine Service
Protective vaccination
Smoking cessation
Hormonal 
contraception
Distribution All pharmacies 86% of pharmacies Varied
Table4  NHS Services provided by community pharmacies in United Kingdom
Source: Choosing health through pharmacy (Department of Health, 2005)
*GPhC-General Pharmaceutical Council
Country Medicine supply
Refill or Repeat
prescribe
Pharmacist
prescribe
Dispensing
doctor
Japan
Blister pack
One dose pack ✕
✕ △
United Kingdom box ○ ○ ✕
Germany box ✕ ✕ ✕
France box ○ ○ ✕
Thailand box/one dose pack ○ ✕ △
Malaysia box/one dose pack ○ ✕ △
1) What dispensing are repeatable within the validity period of the one prescription. 
2) UK: “Auxiliary prescription” based on the physician's prescription. 
“Independent prescription” is carried out in a specialized field.
France: Article 36 of Law Bajuro
3) Japan: A dispensing doctor is recognized by the escape clauses of Article 22 of the Medical Law.
UK, Germany, France: rural and remote
Thailand, Malaysia: Private hospital and Clinic hospital
Table5 Dispensing system
○: recognize, △: some recognize, ✕: no recognize
Color Prescription
Green General Practitioner (GP)’s prescribe
Blue Prescription of controlled drug such as methadone
Yellow Dentist’s prescribe
Lilac
Prescription of pharmacists, nurses recognized “Auxiliary 
prescription” and “Independent prescription”
Fig.3 Prescription category in the United Kingdom
Table6 Regulatory classification of medicine
Japan United Kingdom Germany
Pharmacy only drugs Prescription only medicine
Needed prescription drugs
(Verschreibungspflidhtig)
Non-Prescription drug
ScheduleⅠ
ScheduleⅡ
ScheduleⅢ
Pharmacy medicines
Pharmacy indicator 
(Apothekenpflichtig)
General sales list medicines
Free sale products
(Freiverkauferlich)
France Thailand Malaysia
Presctipyion Medicale
Obligatoire
Specially controlled medicines Group B
Dangerous medicine Group C
Prescription Madicale
Facultative
Ready-packed pharmaceuticals Non-Poisonous
Home remedies
Countries Health promotion services
Japan
Smoking cessation support, Hypertension/Diabetes screening, Asthma screening, Cholesterol 
measurement, Blood pressure measurement, Blood glucose measurement, General nutrition 
counselling, Home care
United 
Kingdom
Smoking cessation support, Hypertension/Diabetes screening, Asthma screening, Weight 
management, Screening risky alcohol use, Emergency contraception, Immunization, Home care
Germany
Smoking cessation support, Hypertension/Diabetes screening, Asthma screening, Weight 
management, Cholesterol measurement, Blood pressure measurement, Blood glucose 
measurement, Prevention of vein thrombosis, Osteoporosis prevention, General nutrition 
counselling, Vaccination counselling, Home care
France
Smoking cessation support, Hypertension/Diabetes screening, Asthma screening, Weight 
management, Emergency contraception, Home care
Thailand
Hypertension/Diabetes screening, Weight management, Nutrition and physical activity, Sexual 
health services, Cardiovascular risk screening 
Malaysia
Weight management, Diabetes counselling, Complementary medicine counseling, Asthma 
counselling, Nutrition and physical activity, Home care
Table7 Health promotion services
